News Column

Agilent Technologies Signs Co-Marketing Deal with MRM Proteomics

July 31, 2014

Agilent Technologies has extended a co-marketing agreement with MRM Proteomics a provider of protein quantitation, biomarker and proteomic services.

According to a company release, the agreement expands on an existing collaboration established in 2012 and will allow both organizations to bolster their combined proteomics solutions, comprising reagent kits, hardware and software.

"MRM Proteomics is a pioneer in the development of mass-spec- based methods for protein quantification and a leading provider of technologies for the pharmaceutical and biotechnology industries," said Steve Fischer, market director for Agilent'sLife Science Research Group. "This collaboration further reflects our commitment to building a comprehensive portfolio of quantitative proteomics solutions for those growing industries."

Proteomics is the study of the structure and function of proteins and how they interact within a complex biological system.

"MRM Proteomics is delighted to expand upon our complementary partnership with Agilent," said Christoph Borchers, chief scientific officer at MRM Proteomics. "Agilent is an ideal partner because of its cutting-edge and high-sensitivity mass spectrometry technologies. The company shares our focus on delivering complete turnkey solutions for targeted quantitative proteomics."

More information and complete details:

www.mrmproteomics.com

www.agilent.com

((Comments on this story may be sent to newsdesk@closeupmedia.com))


For more stories covering the world of technology, please see HispanicBusiness' Tech Channel



Source: Professional Services Close - Up


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters